James P.Joseph II

Associate

Detroit + 1.313.230.7923

James Joseph focuses his practice on helping clients resolve complex commercial disputes. He has helped domestic and international clients navigate their way through both commercial and criminal law issues. James has represented clients in diverse matters such as federal antitrust, trademark infringement, business torts, franchise disputes, contract disputes, immigration law, and federal criminal law. He also has extensive investigative experience, navigating criminal and civil investigations alike for clients.

James' experience with organized labor and labor law issues includes bargaining at the table and first chairing multiple arbitrations governed by collective bargaining agreements as well as advocacy before the National Labor Relations Board (NLRB). James frequently represents clients such as food producers, automotive manufacturers, and tier-one suppliers in disputes involving collective bargaining rights, commercial contracts, franchise agreements, and technology licensing.

James has advised multiple health care systems in best practices and compliance under the Controlled Substances Act, and he has helped these providers in creating proactive and robust compliance programs to address issues of diversion and patient safety.

During the COVID-19 pandemic, James was part of a team tasked with analyzing Michigan's executive orders and advised health care providers on best practices under the evolving legal framework for providing services in a pandemic.

James has an active pro bono practice that focuses on economic opportunity, helping clients expunge criminal records and representing them in eviction proceedings. He has successfully represented numerous clients in asylum and refugee proceedings.

Experience

  • Chevron buys Pasadena Refining System for $350 million from Petrobras America Inc.Jones Day advised Chevron U.S.A. Inc., a wholly-owned subsidiary of Chevron Corporation, in its purchase of all of the equity interests of Pasadena Refining System Inc. ("PRSI") and PRSI Trading, LLC from Petrobras America Inc. for $350 million, subject to adjustments for working capital.
  • Hospital system conducts investigation of circumstances leading to criminal prosecution of employeeJones Day was retained by a multi-state health care system to conduct an investigation and advise the board regarding the practices of hospital staff and leadership regarding a sensitive issue that resulted in a criminal prosecution of an individual who worked at the hospital.
  • Rite Aid Corporation sells 1,932 stores, three distribution centers, and related inventory to Walgreens Boots Alliance for $4.4 billion in cash.Jones Day advised Rite Aid Corporation as Antitrust counsel in the sale of 1,932 stores, three distribution centers, and related inventory to Walgreens Boots Alliance, Inc. for $4.4 billion in cash.
  • GM resolves lawsuit brought by Cadillac dealership over proposed termination of dealer agreementOn behalf of General Motors LLC, Jones Day negotiated a voluntary dismissal of a lawsuit brought by one of the nation's largest Cadillac dealerships regarding the proposed termination of the dealer's distribution agreement.
  • Board of Trustees conducts internal investigation into allegations that football program covered up sexual assault incidentsJones Day was retained by the Board of Trustees of a national university to conduct an internal investigation into whether the university's Division 1 football program violated university policy and other laws by covering up incidents of sexual assault involving football players.
  • Additional Publications

    • May-June 2020
      Better a Step Ahead Than a Step Behind: The Benefits of Proactive Opioid Diversion and Loss Reporting to Regulators and Law Enforcement, Hollenbeck, Gabel, and Joseph, 22 No. 3 J. Health Care Compliance 45
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.